Joel Greenblatt Axonics, Inc. Transaction History

Gotham Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $8,512 - $10,939	175 Added 2.82%	6,387 $358,000
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $858,733 - $1.08 Million	-17,894 Reduced 74.23%	6,212 $313,000
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $102,096 - $130,706	1,941 Added 8.76%	24,106 $1.32 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $710,431 - $913,684	-11,928 Reduced 34.99%	22,165 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $1.98 Million - $2.66 Million	34,093 New	34,093 $2.4 Million

235

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.